Quantitative magnetic resonance imaging indicates brain tissue alterations in patients after liver transplantation

PLoS One. 2019 Sep 25;14(9):e0222934. doi: 10.1371/journal.pone.0222934. eCollection 2019.

Abstract

Purpose: To investigate cerebral microstructural alterations in patients treated with calcineurin inhibitors (CNI) after orthotopic liver transplantation (OLT) using quantitative magnetic resonance imaging (qMRI) and a cross-sectional study design.

Methods: Cerebral qMRI was performed in 85 patients in a median 10 years after OLT compared to 31 healthy controls. Patients were treated with different dosages of CNI or with a CNI-free immunosuppression (CNI-free: n = 19; CNI-low: n = 36; CNI-standard: n = 30). T2-, T2*- and T2'- relaxation times, as well as apparent diffusion coefficient (ADC) and fractional anisotropy (FA) were measured in brain gray and white matter by using the regions of interest method.

Results: In comparison to controls, patients revealed significantly increased T2, T2*, T2', ADC and reduced FA, predominantly in the frontal white matter, indicating microstructural brain alterations represented by increased free water (increased T2), reduced neuronal metabolism (increased T2') and a lower degree of spatial organization of the nervous fibers (reduced FA). CNI-low and CNI-free patients showed more alterations than CNI-standard patients. Analysis of their history revealed impairment of kidney function while under standard CNI dose suggesting that these patients may be more vulnerable to toxic CNI side-effects.

Conclusion: Our findings suggest that the individual sensitivity to toxic side effects should be considered when choosing an appropriate immunosuppressive regimen in patients after liver transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Calcineurin Inhibitors / adverse effects*
  • Cross-Sectional Studies
  • Diffusion Tensor Imaging
  • Female
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control
  • Gray Matter / diagnostic imaging
  • Gray Matter / drug effects*
  • Humans
  • Immunosuppression Therapy / adverse effects*
  • Immunosuppression Therapy / methods
  • Liver Transplantation / adverse effects*
  • Male
  • Middle Aged
  • White Matter / diagnostic imaging
  • White Matter / drug effects*

Substances

  • Calcineurin Inhibitors

Grants and funding

This study was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO1302) to LLG and German Research Foundation (DFG) to BS. We acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Fund of Hannover Medical School (MHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.